Bolt Biotherapeutics Inc - Nakit Akışı (NASDAQ:BOLT) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -57.07 M-76.5 M-69.53 M-61.29 M-39.85 M -39.85 M Yatırım faaliyetlerinden elde edilen nakit -232.2 M57.86 M71.04 M57.58 M44.3 M 44.3 M Finansman faaliyetlerinden elde edilen nakit 311.11 M503 K253 K108 K19 K 19 K Free cash flow -59.4 M-78.46 M-69.73 M-61.33 M-39.92 M -39.85 M

Haberler

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics CEO’su Quinn 686 dolarlık hisse satın aldı

Nemec, Bolt Biotherapeutics Kıdemli Başkan Yardımcısı, 686 dolarlık hisse satın aldı

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

H.C. Wainwright, Bolt Biotherapeutics hissesi için Alım tavsiyesi verdi

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)

Bolt Biotherapeutics klinik verileri erteliyor, iş gücünü yarıya indiriyor

Bolt Biotherapeutics delays clinical data, cuts workforce by half